FGF21 and metabolic dysfunction-associated steatotic liver disease: Hepatic production of FGF21 is increased under liver injury, viral infection, chemical insult, hepatosteatosis, steatohepatitis, NAFLD, cirrhosis, and liver cancer [43,45,46,47].